Champix by Pfizer
Dear Advisory Committee on Prescription Medicines,
When did the ACSOM committee last meet to discuss the adverse effects of taking "CHAMPIX" & what was the resolution & findings as a result of this meeting
Yours faithfully,
Rod Hamblin
Dear Mr Hamblin
I refer to your FOI request of 17 September 2015 to the Department of
Health (as below).
Section 15 of the FOI Act requires that a request for documents meets
certain requirements. Your request, in its current form, does not
constitute a valid request. Please note that the Act provides for access
to documents and not to 'information'. In order for your request to be
processed under the provisions of the FOI Act you must provide us with
further information to enable us to identify the document or documents you
are seeking.
For example, you may wish to consider submitting the following scope:
“Ratified minutes from any Advisory Committee on the Safety of
Prescription Medicines (ACSOM) meeting where CHAMPIX was discussed.”
Please note that this scope is a sample only. At this early stage, a
search and retrieval has not been conducted and the TGA is unable to
advise on whether it may be too voluminous to process or if any documents
will be returned.
Please do not hesitate to contact me if you would like to discuss this
further.
Kind regards
Liz
Freedom of Information
Liz Santolin 02 6232 8664
Emily May 02 6232 8792
Karen Bedford 02 6232 8772
Planning, Reporting and Stakeholder Support Section
Regulatory Engagement and Planning Branch
Therapeutic Goods Administration
Address: PO Box 100, Woden ACT, 2606
Email: [1][email address]
[2]cid:image003.gif@01CFA69C.488B9550